Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Melanoma × gadopiclenol × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Meningeal Neoplasms 1 Melanoma 1 Lung Neoplasms 1

Interventions

Nivolumab 6 Ipilimumab 4 relatlimab 3 pembrolizumab 2 cemiplimab 2 Melphalan 2 Interleukin-2 2 trametinib 1 toripalimab 1 sulforaphane 1 secukinumab 1 gadopiclenol 1 famitinib 1 encorafenib 1 binimetinib 1 anlotinib 1 Toll-Like Receptor 1 1 Therapeutics 1 Temozolomide 1 Standard of Care 1 Specimen Handling 1 SHR-1701 1 Rehabilitation 1 Pemetrexed 1 Paclitaxel 1 Interviews as Topic 1 Injections 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡